Seres Therapeutics, Inc. (MCRB)
NASDAQ: MCRB · Real-Time Price · USD
16.68
+0.71 (4.45%)
Aug 14, 2025, 2:14 PM - Market open
Seres Therapeutics Revenue
Revenue (ttm)
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
103
Market Cap
146.03M
Revenue Chart
Revenue History
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
UnitedHealth Group | 422.82B |
Johnson & Johnson | 90.63B |
Merck & Co. | 63.62B |
AbbVie | 58.33B |
AstraZeneca | 56.50B |
Novartis AG | 55.19B |
Eli Lilly and Company | 53.26B |
Novo Nordisk | 49.11B |
MCRB News
- 7 days ago - Seres Therapeutics, Inc. (MCRB) Q2 2025 Earnings Call Transcript - Seeking Alpha
- 8 days ago - Seres Therapeutics Reports Second Quarter 2025 Financial Results and Provides Business Updates - GlobeNewsWire
- 16 days ago - Seres Therapeutics: Speculative Gem Backed By SER‑155 FDA Breakthrough - Seeking Alpha
- 23 days ago - Seres Therapeutics to Announce Second Quarter 2025 Financial Results and Business Updates on August 6, 2025 - GlobeNewsWire
- 23 days ago - Seres Therapeutics Announces Leadership Transition - GlobeNewsWire
- 2 months ago - Seres Therapeutics Presents Expanded SER-155 Exploratory Biomarker Data at 2025 ASCO Annual Meeting - GlobeNewsWire
- 3 months ago - Seres Therapeutics, Inc. (MCRB) Q1 2025 Earnings Call Transcript - Seeking Alpha
- 3 months ago - Seres Therapeutics Reports First Quarter 2025 Financial Results and Provides Business Updates - GlobeNewsWire